Clinical Trials Logo

Keratitis clinical trials

View clinical trials related to Keratitis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05123014 Active, not recruiting - Clinical trials for Adenoviral Keratoconjunctivitis

Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Adenoviral keratitis(caused by adenovirus) is one of the most frequently diagnosed eye diseases. Most of these infections have symptoms like (Ocular itchiness and irritation, chemosis (conjunctival edema),photophobia, epiphora, foreign body sensation, epithelial keratitis etc.Adenoviral subepithelial infiltration is one of the most difficult complication to treat. Our purpose is to evaluate corneal transparency, recurrence, and visual acuity in patients with adenoviral subepithelial infiltration by first removing the infiltrative stroma with a smile and implanting the same volume of fresh lenticule in the prepared stromal pocket.

NCT ID: NCT04097730 Active, not recruiting - Keratitis Bacterial Clinical Trials

Steroids and Cross-linking for Ulcer Treatment

SCUT II
Start date: September 24, 2020
Phase: Phase 3
Study type: Interventional

Steroids and Cross-linking for Ulcer Treatment (SCUT II) is an international, randomized, double-masked, clinical trial. The purpose of this study is to determine differences in 6-month visual acuity between medical antimicrobial treatments alone versus antimicrobial treatment plus collagen cross-linking (CXL), as well as to further evaluate findings from subgroup analyses of SCUT. Patients presenting to the Aravind Eye Care System (India), Kaiser Permanente Northern California (USA), or the University of California, San Francisco (USA) with smear-positive and/or culture-positive typical (i.e. non-Nocardia or Mycobacteria) bacterial corneal ulcers and moderate to severe vision loss, defined as Snellen visual acuity of 20/40 or worse, will be eligible for inclusion. Those who agree to participate will be randomized to one of three treatment groups: Group 1: Standard therapy, topical 0.5% moxifloxacin plus topical placebo plus sham CXL Group 2: Early steroids, topical 0.5% moxifloxacin plus topical difluprednate 0.05% plus sham CXL Group 3: CXL plus early steroids, topical 0.5% moxifloxacin plus topical difluprednate 0.05% plus CXL

NCT ID: NCT03484507 Active, not recruiting - Clinical trials for Acanthamoeba Keratitis

Parasitic Ulcer Treatment Trial Pilot

Start date: January 1, 2018
Phase: Phase 2
Study type: Interventional

This is a study of optimal treatments for acanthamoeba keratitis. In the first part of the study, participants will be randomized to chlorhexidine monotherapy or chlorhexidine plus povidone iodine. After four weeks of therapy, participants will be re-randomized to early corticosteroids, later corticosteroids, or placebo.

NCT ID: NCT03138785 Active, not recruiting - Treatment Clinical Trials

UVX as an Adjuvant in the Treatment of Fungal Keratitis

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

In this study, investigators want to find the effect of adjuvant collagen cross-linking in the treatment of fungal keratitis

NCT ID: NCT02716883 Active, not recruiting - Clinical trials for Keratitis of Both Eyes

Early Amniotic Membrane Transplantation in Bacterial Keratitis

Start date: January 2014
Phase: N/A
Study type: Interventional

In this study Investigators are going to do early amniotic membrane transplantation (AMT) for bacterial keratitis.

NCT ID: NCT00492245 Active, not recruiting - Keratitis Clinical Trials

Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities

Start date: April 2006
Phase: N/A
Study type: Interventional

The present study was designed to evaluate the treatment of adenoviral corneal opacities with PTK and mitomycin C.

NCT ID: NCT00000138 Active, not recruiting - Keratitis, Herpetic Clinical Trials

Herpetic Eye Disease Study (HEDS) I

Start date: May 1989
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of topical corticosteroids in treating herpes simplex stromal keratitis in conjunction with topical trifluridine. To evaluate the efficacy of oral acyclovir in treating herpes simplex stromal keratitis in patients receiving concomitant topical corticosteroids and trifluridine. To evaluate the efficacy of oral acyclovir in treating herpes simplex iridocyclitis in conjunction with treatment with topical corticosteroids and trifluridine.